Biopharm Co. Holds 2026 Interim Results Briefing

Biopharm Co. held its 2026 interim results briefing on September 1, 2026.

The company used the occasion to present its financial and operational performance for the first half of the year, and to respond to questions from investors and analysts. The briefing covered key business developments and financial metrics for the six months ended June 30, 2026, offering stakeholders a detailed overview of the company's results during the reporting period.